Clinical trial
Safety and Efficacy of MultiHance in Pediatric Patients
NCT00323310 · Bracco Diagnostics, Inc, Industry · Terminated
Key facts
| NCT number | NCT00323310 |
|---|---|
| Title | Safety and Efficacy of MultiHance in Pediatric Patients |
| Official title | A Phase III Multi-Center Open Label Study to Evaluate Safety and Efficacy of MultiHance at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Central Nervous System Diseases |
| Intervention type | Drug |
| Interventions | gadobenate dimeglumine |
| Enrollment | 92 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | May 9, 2006 |
| Last update posted | Oct 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: